
Dr
George Cherry

Professor Mark Ferguson
|
At
the beginning of February the Board met at the venue of our 17th
Annual meeting of the ETRS which will be held in Southampton at
the excellent facility which our President Karin Scharffetter-Kochanek
describes in her letter in this issue, highlighting its features.
Raj Mani, organiser and congress president, along with the organising
company, Convenus, have made an excellent choice which will be complemented
by an excellent scientific and clinical programme. As Karin has
outlined in her letter, the Society is offering a number of awards
and financial initiatives to young researchers and students to encourage
their attendance at this important meeting. The website for the
meeting is: <www.etrs2007soton.com>
In this issue we have an introduction to our new Board members,
Dr Magda Ulrich, Dutch Burns Foundation, The Netherlands and Dr
Boris Hinz, Ecole Polytechnique Fédérale de Lausanne,
Switzerland.
The work of Dr Hinz’s laboratory is directed at understanding
the biophysics of cell contractility which is extremely important
in normal scarring and in many clinical conditions such as Dupuytren’s
disease and fibrosis affecting vital organs. Boris Hinz was a postdoctoral
fellow with Professor Giulio Gabbiani in Geneva. Professor Gabbiani
was one of the founding members of the ETRS and continues to support
the Society in participating in focus meetings, particularly
a recent one he co-organised with Professor Alexis Desmouliere and
Dr Christine Chaponnier.at Nyon, Switzerland.
Mark Ferguson, a major supporter of ETRS since its founding, has
completed his rôle as secretary of the Society, which has
been taken up by Dave Thomas of Cardiff. Earl Peacock, a surgeon
and collagen researcher, pointed out in 1983 that ‘nowhere
is the gap between basic research and clinical application more
glaring than in the biology of wound healing.’ Mark’s
experimental work into scarring, with colleagues like Whitby and
others, helped us understand
some of the mechanisms of scarless healing in embryonic wounds and
has led to clinical applications which are contributing to closing
the gap referred to by Peacock. Recent clinical trials by his group
on scarring have ranged from treating post-surgical scars with positive
outcomes to preventative studies. Further utilisation of these treatments
on other organs such as the eye and tendon are planned.
On personal reflection I first met Mark at the first Wound Healing
Society meeting in Galveston, Texas in 1991 where I learned about
his work, as well as at our Annual ETRS meetings. With my colleague,
Dr Margaret Hughes, I have been aware of the details of the research
of many of his doctoral students working in this field in his university
laboratory. On behalf of the ETRS I would like to thank Mark for
his work as Secretary over the years and I am sure he will
continue to take part and contribute to many of our future activities.
Dr George Cherry
Editor
|